Clinical trials and real-world studies have consistently demonstrated its effectiveness in lowering blood glucose levels and HbA1c, a key indicator of long-term glycemic control
Most patients notice appetite suppression beginning around weeks 4 to 8, as the dose moves above the tolerability phase
Seek medical advice if you experience severe or persistent cramps, frequent daily or nightly cramping, associated muscle weakness or numbness, visible muscle swelling or redness, or signs of dehydration such as dizziness or dark urine
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist available under several brand names: Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management
In many medically supervised weight loss programs, we consider a moderate increase in protein intake during active weight loss